Aktieanalys

Acarix: Expanded reimbursement - Redeye

{newsItem.title}

Redeye Publicerad: 04 Nov 2024 11:06

Redeye views today’s press release from Acarix as a positive development, confirming new reimbursement coverage for the CADScor System in emergency and outpatient settings. This announcement marks a milestone for the company, solidifying Acarix's position towards the US market.

Länk till analysen i sin helhet: https://www.redeye.se/research/1051188/acarix-expanded-reimbursement?utm_source=finwire&utm_medium=RSS

Nyheter om Acarix

Läses av andra just nu

Om aktien Acarix

Senaste nytt